Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Essex Bio-Technology ( (HK:1061) ) has provided an update.
Essex Bio-Technology Limited has announced that its board of directors will hold a meeting on August 26, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The board will also consider the potential declaration of an interim dividend, which could impact the company’s financial strategy and shareholder returns.
More about Essex Bio-Technology
Essex Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and marketing biopharmaceutical products, primarily targeting the healthcare sector.
Average Trading Volume: 1,622,743
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.02B
Learn more about 1061 stock on TipRanks’ Stock Analysis page.